Aberdeen Group’s Nurix Therapeutics NRIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-30,537	Closed	-$398K	–	922
2022 Q3	$398K	Buy	+30,537	New	+$398K	﹤0.01%	860
2021 Q4	–	Sell	-19,085	Closed	-$572K	–	1065
2021 Q3	$572K	Buy	+19,085	New	+$572K	﹤0.01%	948